ARTICLE | Clinical News

Applied Immune Sciences Inc. regulatory update

August 7, 1995 7:00 AM UTC

AISX received U.S. Patent No. 5,437,861 covering technology that enables removal of selected factors from whole blood or blood components. The technology consists of particulate silica that is pre-treated with an agent to enable the removal of factors such as pharmaceuticals and cytokines from whole blood or plasma. ...